Table 4

Diagnostic odds ratio (dOR) calculated for each immunohistochemistry marker or combination
IHC ANALYSIS dOR (95% CI) Q P
CK-19 [10,14-33] 14.73 (8.20-26.45) 110.05 <0.00001
GAL-3 [10,14-17,19,21,25-56] 23.41 (14.02-39.07) 252.72 <0.00001
HBME-1 [10,14-19,21,24-27,29,30,41,51,57-61] 40.97 (21.42-78.37) 140.82 <0.00001
CK-19 + HBME-1 [14,17] 119.06 (6.81-2080.37) 2.62 0.1058
GAL-3 + CK-19 [14,17] 86.54 (10.8-693.52) 2.89 0.8292
GAL-3 + HBME-1 [14,17,46,51] 21.94 (2.88-167.49) 21.16 0.0001
GAL-3 + HBME-1 + CK-19 [14,17,29] 95.06 (25.17-359.08) 2.23 0.3280

de Matos et al.

de Matos et al. Diagnostic Pathology 2012 7:97   doi:10.1186/1746-1596-7-97

Open Data